Follow
Katarina Pinjusic
Katarina Pinjusic
Dana-Farber Cancer Institute, Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Time-resolved scanning ion conductance microscopy for three-dimensional tracking of nanoscale cell surface dynamics
SM Leitao, B Drake, K Pinjusic, X Pierrat, V Navikas, AP Nievergelt, ...
ACS nano 15 (11), 17613-17622, 2021
422021
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma
K Pinjusic, OA Dubey, O Egorova, S Nassiri, E Meylan, J Faget, ...
Journal for ImmunoTherapy of Cancer 10 (5), 2022
152022
AB cell–driven EAE mouse model reveals the impact of B cell–derived cytokines on CNS autoimmunity
AS Thomann, CA McQuade, K Pinjušić, A Kolz, R Schmitz, D Kitamura, ...
Proceedings of the National Academy of Sciences 120 (47), e2300733120, 2023
22023
Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING
K Pinjusic, G Ambrosini, J Lourenco, N Fournier, C Iseli, N Guex, ...
Frontiers in Immunology 14, 1335207, 2024
12024
Immunosuppressive roles of Activin-A in melanoma and characterization of its precursor cleavage
K Pinjusic
EPFL, 2022
2022
Utjecaj okadaične kiseline na fosforilaciju proteina tau na epitopima Thr231 i Ser396/Ser404
K Pinjušić
University of Zagreb. Faculty of Science. Department of Biology, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–6